Definitive Contract 75D30120C09658

Award Date 9/28/20
Potential Completion Date 3/27/22
Potential Value $4.8M
Federal Agency
CDC Pittsburgh
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
West McLean, VA 22102, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
1
Legislative Mandate
Service Contract Inventory
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to Insignia Federal Group, LLC, a minority-owned, woman-owned small business based in McLean, Virginia. The $797,127.35 Firm Fixed Price contract is for "Monitoring Changes in Attitudes and Practices Among Family Planning Provider Clinics-Phase III." It was awarded on August 22, 2016 with a completion date of November 28, 2019. The contract was awarded under an 8(a) Sole Source set-aside....
Insignia Federal Group, LLC was awarded a delivery order against its GSA Schedule 70 contract to provide data analysis and visualization services supporting the Department of Health and Human Services Administration for Children and Families' plan to end the HIV epidemic in America. Valued at up to $4,269,545.63, this time and materials contract has a period of performance through September 2022. Operating under the IT-70 vehicle, Insignia Federal Group will leverage its expertise in health...
This is a delivery order contract awarded to Insignia Federal Group, LLC, a minority and woman-owned small business, by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) to provide program and data management technical support. The award is a firm fixed price delivery order with a potential value of $1,006,730.16. The contract does not have a set-aside designation. Insignia Federal Group is the prime contractor and the place of performance is...
This is a $91,562 firm-fixed price purchase order awarded by the Centers for Disease Control and Prevention (CDC) Office of Acquisition Services to Insignia Federal Group, LLC, a minority-owned, woman-owned small business. The contract is for technical and programmatic support services and was awarded as an 8(a) sole source set-aside. Insignia Federal Group is a prime contractor on the One Acquisition Solution for Integrated Services - Small Business (OASIS SB) and Human Capital and Training...
This federal contract, award ID HHSD200201795203I|75D30119F00006, was awarded by the Centers for Disease Control and Prevention (CDC) to the prime contractor Insignia Federal Group, LLC for the project "BUILDING CAPACITY FOR MATERNAL AND CHILD HEALTH EPIDEMIOLOGIC ANALYSIS AND TRANSLATION." The $401,430.40 cost-plus-fixed-fee contract has a completion date of September 29, 2020 and was awarded on September 30, 2019. Insignia Federal Group is a minority-owned, woman-owned small business...
The U.S. Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $459,305.75 firm-fixed-price delivery order contract to Insignia Federal Group, LLC, a minority-owned, woman-owned small business, to provide building capacity for maternal and child health epidemiologic analysis and translation services. The contract was awarded on July 31, 2019, with a completion date of November 30, 2020. Insignia Federal Group, which does business as Insignia Federal...
This is a $563,588.44 cost-plus-fixed-fee delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Insignia Federal Group, LLC, a minority-owned, woman-owned small business based in McLean, Virginia. The contract is for "Building Capacity for Maternal and Child Health Epidemiologic Analysis and Translation" and has an ultimate completion date of April 2, 2020. Insignia Federal Group is not performing this work under a set-aside contract. The contract...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $24,069.52 purchase order to Fujirebio US, Inc. for INNO-LIA HIV I/II SCORE tests. Fujirebio US, Inc. will deliver the tests from its division location in Chamblee, Georgia under the firm fixed price contract, which runs from July 20 through September 30, 2023. No set aside designation or subcontractors were indicated. The Centers for Disease Control and Prevention works to protect...
This is a delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention (HHS CDC) to Insignia Federal Group, LLC, a minority and woman-owned small business, for the "BUILDING CAPACITY FOR MATERNAL AND CHILD HEALTH EPIDEMIOLOGIC ANALYSIS AND TRANSLATION" task order. The $1,220,575.74 firm fixed price contract has a completion date of January 22, 2020 and was awarded on January 23, 2018. Insignia Federal Group, a professional services...
This is a firm-fixed-price delivery order awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to Insignia Federal Group, LLC, a minority-owned, woman-owned small business. The $853,825.93 task order is for building capacity for maternal and child health epidemiologic analysis and translation, with a completion date of March 6, 2018. Insignia Federal Group has prime and subcontract experience providing services like IT, management consulting, and...

Insignia Federal Group, LLC was awarded a $4.8 million firm-fixed-price contract by the Centers for Disease Control and Prevention to support its demonstration project evaluating uptake of HIV self-testing. Under the terms of the contract, Insignia Federal Group will procure up to 100,000 FDA-approved HIV rapid self-test kits and provide associated online ordering and fulfillment services through March 2022. The total small business set-aside contract was awarded under a solicitation seeking a contractor to distribute test kits via an online platform capable of handling variable daily demand as part of CDC's efforts to advance HIV prevention and control programs. Insignia Federal Group will submit monthly usage data reports on test kit distribution to allow CDC to evaluate the demonstration project's impact on self-testing uptake.

Generated 12/29/23, 5:02 PM